Scientists test gene therapy to restore vision in blinding eye disease
NCT ID NCT04278131
Summary
This trial is testing a new gene therapy called BS01 for people with retinitis pigmentosa, a genetic eye disease that causes vision loss. The therapy uses a harmless virus to deliver a special light-sensitive protein directly into the eye, aiming to help remaining cells detect light and improve vision. Researchers will first check if the treatment is safe and then see if it helps patients see light, motion, and shapes better.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
New Jersey Retina
RECRUITINGTeaneck, New Jersey, 07666, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.